Ortivus AB ser. B

ORTI-B · Nasdaq Stockholm · Healthcare

1.52SEK −3.8%last day

Price as of 2 October 2026

The price over the past year, with dividends: +49.0%

Performance

1 month

−15.1%

1 year

+49.0%

3 years, per year

−16.9%

5 years, per year

−21.0%

Largest fall, 3 years

−83.7%

Below the peak now

−98.9%

Volatility, 1 year

85.8%

Return with dividends reinvested.

Key figures

P/E

negative earnings

P/B

7.3

Dividend yield

0.0%

Return on equity

−100.3%

Net margin

−23.4%

Market value

13 m USD

Quality, value and trend

Where Ortivus stands against every Nordic stock today. 100 is best.

Quality23

Profitability and a sound balance sheet over time. Better than 23% of Nordic stocks.

Value16

The price measured against earnings, assets and cash flow. Better than 16% of Nordic stocks.

Trend66

The price development over the past year. Better than 66% of Nordic stocks.

Combined20

Quality, value and trend together. Better than 20% of Nordic stocks.

About Ortivus

Ortivus AB ser. B is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 32 employees.

Ortivus AB (publ) develops and commercializes medical technology solutions and e-health for healthcare industry in Sweden and internationally. The company offers MobiMed Monitor that monitor and shares vital signs and ECG; MobiMed ePR, an electronic patient record system for documentation of treatment and events; MobiMed enRoute, a navigation, case management, and mass casualty management; MobiMed FleetCtrl, a a software application that regular controls, checklists, and documentation tailored for seamless fleet management; MobiMed Life, a heart safe solution. It also provides emergency medical services, primary care, and rescue services.

See the full analysis in InvestWiser.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

See the full analysis